Literature DB >> 3316926

In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies.

D Smith1, L Rossetti, E Ferrannini, C M Johnson, C Cobelli, G Toffolo, L D Katz, R A DeFronzo.   

Abstract

The goals of this study were twofold: (1) to determine the in vivo dose-response relationship in the conscious, unstressed rat between the plasma insulin concentration and total body glucose uptake, and between plasma insulin and suppression of endogenous glucose production; and (2) to develop a physiologic compartmental model to describe the kinetics of plasma glucose in the rat in the basal state. In order to perform repeat insulin clamp studies in the same rat, chronic catheters were implanted in the aortic arch (via the carotid artery) and in the cardiac atrium (via the jugular vein), exteriorized, and fixed to the back of the skull with a dental cement cap. Insulin was infused at rates of 1.2, 2.4, 4.8, 12, and 24 mU/min.kg, and the plasma glucose was held constant at the basal level by a variable glucose infusion (euglycemic insulin clamp). The resulting steady-state plasma insulin concentrations ranged from 40 to 1,300 microU/mL. The dose-response curve for glucose uptake was sigmoidal in shape: in the basal state, total glucose utilization averaged 6.8 mg/min.kg at an insulin concentration of 9 microU/mL, half-maximal glucose uptake (18.3 mg/kg.min) occurred at a plasma insulin concentration between 70 and 80 microU/mL, and maximal uptake (36.6 mg/kg.min) was seen at an insulin level in excess of 100 microU/mL. Residual endogenous glucose production was evaluated by a prime-continuous infusion of (3-3H)-glucose. The dose-response curve for suppression of endogenous glucose output also was sigmoidal.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3316926     DOI: 10.1016/0026-0495(87)90244-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

1.  Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp.

Authors:  Tiffany D Farmer; Erin C Jenkins; Tracy P O'Brien; Gregory A McCoy; Allison E Havlik; Erik R Nass; Wendell E Nicholson; Richard L Printz; Masakazu Shiota
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

2.  Effect of aging and obesity on insulin responsiveness and glut-4 glucose transporter content in skeletal muscle of Fischer 344 x Brown Norway rats.

Authors:  L M Larkin; T H Reynolds; M A Supiano; B B Kahn; J B Halter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-11       Impact factor: 6.053

3.  S15261, a new compound for the treatment of the insulin resistance syndrome.

Authors:  J Duhault; F Lacour; M Boulanger; O Della-Zuana; D Ravel; M Wierzbicki; J Espinal
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

4.  Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.

Authors:  S J Koopmans; A D van Mansfeld; H S Jansz; H M Krans; J K Radder; M Frölich; S F de Boer; D K Kreutter; G C Andrews; J A Maassen
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

5.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.

Authors:  A D Baron; J S Zhu; J H Zhu; H Weldon; L Maianu; W T Garvey
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  A Comparative Study of the Effect of Gastric Bypass, Sleeve Gastrectomy, and Duodenal-Jejunal Bypass on Type-2 Diabetes in non-Obese Rats.

Authors:  Bo Xu; Xiaojie Yan; Yikai Shao; Qiwei Shen; Rong Hua; Rui Ding; Qiyuan Yao
Journal:  Obes Surg       Date:  2015-10       Impact factor: 4.129

7.  Basal glucose turnover in Psammomys obesus. An animal model of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  R C Habito; M Barnett; A Yamamoto; D Cameron-Smith; K O'Dea; P Zimmet; G R Collier
Journal:  Acta Diabetol       Date:  1995-10       Impact factor: 4.280

8.  Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.

Authors:  R Shankar; J S Zhu; B Ladd; D Henry; H Q Shen; A D Baron
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  Acute effects of insulin-like growth factor I on glucose and amino acid metabolism in the awake fasted rat. Comparison with insulin.

Authors:  R Jacob; E Barrett; G Plewe; K D Fagin; R S Sherwin
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

10.  In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia.

Authors:  A Giaccari; L Morviducci; D Zorretta; P Sbraccia; F Leonetti; S Caiola; A Buongiorno; R C Bonadonna; G Tamburrano
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.